Literature DB >> 12428812

Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders.

Mark P Mattson1, Dong Liu.   

Abstract

As in other cells, neurons use adenosine triphosphate (ATP) as an energy source to drive biochemical processes involved in various cell functions, and produce reactive oxygen species (ROS) as "by products" of oxidative phosphorylation. However, the electrical excitability and structural and synaptic complexity of neurons present unusual demands upon cellular systems that produce or respond to ATP and ROS. Mitochondria in axons and presynaptic terminals provide sources of ATP to drive the ion pumps that are concentrated in these structures to rapidly restore ion gradients following depolarization and neurotransmitter release. Mitochondria may also play important roles in the regulation of synaptic function because of their ability to regulate calcium levels and ROS production. ROS generated in response to synaptic activity are now known to contribute to the regulation of long-term structural and functional changes in neurons, and the best-known example is the nitric oxide radical. The high-energy demands of synapses, together with their high levels of ROS production, place them at risk during conditions of increased stress, which occur in aging, neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, and after acute traumatic and ischemic insults. Energy depletion and/or increased oxidative damage to various synaptic proteins can result in a local dysregulation of calcium homeostasis and synaptic degeneration. Accordingly, recent studies have shown that dietary and pharmacological manipulations that improve energy efficiency and reduce oxyradical production can prevent synaptic degeneration and neuronal death in experimental models of neurodegenerative disorders. A better understanding of the molecular control of subcellular energy production and utilization, and of the functional relationships between energy metabolism, ion homeostasis, and cytoskeletal and vesicular dynamics, will provide novel insight into mechanisms of neuronal plasticity and disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428812     DOI: 10.1385/NMM:2:2:215

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  108 in total

1.  Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis.

Authors:  D S Gary; M P Mattson
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

Review 2.  The voltage-dependent anion channel: an essential player in apoptosis.

Authors:  Yoshihide Tsujimoto; Shigeomi Shimizu
Journal:  Biochimie       Date:  2002 Feb-Mar       Impact factor: 4.079

3.  Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF.

Authors:  B Cheng; M P Mattson
Journal:  Exp Neurol       Date:  1992-08       Impact factor: 5.330

Review 4.  Calcium regulation of the neuronal growth cone.

Authors:  S B Kater; M P Mattson; C Cohan; J Connor
Journal:  Trends Neurosci       Date:  1988-07       Impact factor: 13.837

5.  Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger.

Authors:  T J O'Dell; R D Hawkins; E R Kandel; O Arancio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

6.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

Review 7.  Neuroimaging in bipolar disorder.

Authors:  S M Strakowski; M P DelBello; C Adler; D M Cecil; K W Sax
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

8.  In vivo 2-deoxyglucose administration preserves glucose and glutamate transport and mitochondrial function in cortical synaptic terminals after exposure to amyloid beta-peptide and iron: evidence for a stress response.

Authors:  Z H Guo; M P Mattson
Journal:  Exp Neurol       Date:  2000-11       Impact factor: 5.330

9.  Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients.

Authors:  W A Pedersen; W Fu; J N Keller; W R Markesbery; S Appel; R G Smith; E Kasarskis; M P Mattson
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

10.  Phosphatidylinositol-3-kinase-Akt kinase and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein.

Authors:  Guanjun Cheng; ZaiFang Yu; Daohong Zhou; Mark P Mattson
Journal:  Exp Neurol       Date:  2002-06       Impact factor: 5.330

View more
  56 in total

Review 1.  DNA repair in photoreceptor survival.

Authors:  M Soledad Cortina; William C Gordon; Walter J Lukiw; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2003-10       Impact factor: 5.590

2.  Voltammetric detection of hydrogen peroxide at carbon fiber microelectrodes.

Authors:  Audrey L Sanford; Stephen W Morton; Kelsey L Whitehouse; Hannah M Oara; Leyda Z Lugo-Morales; James G Roberts; Leslie A Sombers
Journal:  Anal Chem       Date:  2010-06-15       Impact factor: 6.986

Review 3.  Sources and targets of reactive oxygen species in synaptic plasticity and memory.

Authors:  Kenneth T Kishida; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2007-02       Impact factor: 8.401

Review 4.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

5.  Cockayne syndrome group B protein stimulates repair of formamidopyrimidines by NEIL1 DNA glycosylase.

Authors:  Meltem Muftuoglu; Nadja C de Souza-Pinto; Arin Dogan; Maria Aamann; Tinna Stevnsner; Ivana Rybanska; Güldal Kirkali; Miral Dizdaroglu; Vilhelm A Bohr
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

6.  Preventing NAD(+) depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction.

Authors:  Dong Liu; Michael Pitta; Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 7.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 8.  Exercise and brain health--implications for multiple sclerosis: Part 1--neuronal growth factors.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

9.  Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons.

Authors:  Dong Liu; Robert Gharavi; Michael Pitta; Marc Gleichmann; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-03-14       Impact factor: 3.843

10.  Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.

Authors:  Todd E Golde; Victor M Miller
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.